Table 1.

Effects of ethanol (EtOH) and drug treatments on I_tonic amplitude, mIPSC area and mIPSC frequency.

	Itonic amplitude (pA)		mIPSC area (fC)		mIPSC Frequency (Hz)
	Baseline	Acute EtOH	Baseline	Acute EtOH	Baseline	Acute EtOH
Ctrl	22.2 ± 0.9	36.6 ± 3.0†	2995.3 ± 232.5	2705.1 ± 193.7	2.47 ± 0.18	2.54 ± 0.21
E/W	8.5 ± 0.5	9.9 ± 0.7*	2615.5 ± 276.5	2648.3 ± 211.7	2.56 ± 0.23	2.65 ± 0.21
Che + E/W	18.9 ± 1.1	31.8 ± 1.7†	2895.7 ± 254.6	2791.6 ± 305.9	2.36 ± 0.16	2.45 ± 0.15
Che	20.8 ± 1.5	33.3 ± 2.2†	2811.4 ± 297.9	2855.4 ± 224.1	2.49 ± 0.26	2.62 ± 0.24
PDBu + E/W	6.1 ± 0.6	6.9 ± 0.6*	2508.3 ± 226.2	2811.1 ± 297.9	2.28 ± 0.23	2.32 ± 0.23
PDBu	13.1 ± 0.7	16.1 ± 0.8*	2805.8 ± 258.2	2592.9 ± 232.5	2.45 ± 0.20	2.57 ± 0.18
H89 + E/W	6.9 ± 0.5	7.6 ± 0.6*	2682.0 ± 312.7	2772.3 ± 148.4	2.32 ± 0.16	2.43 ± 0.20
H89	20.0 ± 0.7	31.3 ± 1.8†	2888.2 ± 208.5	2801.8 ± 225.0	2.60 ± 0.12	2.67 ± 0.17
Forskolin + E/W	7.0 ± 0.8	8.2 ± 0.9*	2662.5 ± 200.7	2504.7 ± 185.3	2.23 ± 0.18	2.35 ± 0.17
Forskolin	20.9 ± 1.2	34.1 ± 1.7†	2516.8 ± 150.2	2690.0 ± 219.5	2.16 ± 0.24	2.15 ± 0.17

n = 11–14 per group. ^†p < 0.001 vs. the pre-EtOH baseline value, *p < 0.001 vs. Ctrl group (two-way ANOVA with post hoc Holm-Sidak test).